Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
-741K
-
Total reported value, excl. options
-
$22.9M
-
Value change
-
-$1.59M
-
Number of buys
-
21
-
Number of sells
-
-14
-
Price
-
$1.43
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q1 2024
48 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q1 2024.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 153M outstanding shares and own 10.45% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (5.35M shares), AIGH Capital Management LLC (3.32M shares), Telemark Asset Management, LLC (1.33M shares), ESSEX INVESTMENT MANAGEMENT CO LLC (926K shares), WELLS FARGO & COMPANY/MN (893K shares), VANGUARD GROUP INC (808K shares), Opaleye Management Inc. (535K shares), BlackRock Inc. (403K shares), GEODE CAPITAL MANAGEMENT, LLC (385K shares), and Legato Capital Management LLC (334K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.